Overview

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

Status:
Completed
Trial end date:
2019-07-02
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, double-dummy, placebo-controlled, cross over design trial with empagliflozin compared to placebo that is added to open-label ramipril.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Collaborator:
Eli Lilly and Company
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Empagliflozin
Ramipril